Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Urinary Antibacterial Activity Of BAL30072 Against Uropathogens After IV Administration

Trial Profile

Urinary Antibacterial Activity Of BAL30072 Against Uropathogens After IV Administration

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2016

At a glance

  • Drugs BAL 30072 (Primary)
  • Indications Bacterial infections; Urinary tract infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 14 Mar 2016 Results (n=19) published in the Antimicrobial Agents and Chemotherapy.
    • 17 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top